Literature DB >> 14532120

SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

K G Suresh Kumar1, Weigang Tang, Abhilash K Ravindranath, William A Clark, Ed Croze, Serge Y Fuchs.   

Abstract

Down-regulation of activated signaling receptors in response to their ligands plays a key role in restricting the extent and duration of the signaling. Mechanisms underlying down-regulation of the type I interferon receptor consisting of IFNAR1 and IFNAR2 subunits remain largely unknown. Here we show that IFNAR1 interacts with the Homolog of Slimb (HOS) F-box protein in a phosphorylation-dependent manner, and that this interaction is promoted by interferon alpha (IFNalpha). IFNAR1 is ubiquitinated by the Skp1-Cullin1-HOS-Roc1 (SCF(HOS)) ubiquitin ligase in vitro. HOS expression and activities are required for IFNalpha-stimulated ubiquitination of IFNAR1, endocytosis of the type I interferon receptor, down-regulation of IFNAR1 levels, and IFNAR1 proteolysis via the lysosomal pathway. Furthermore, modulations of HOS activities affect the extent of Stat1 phosphorylation and Stat-mediated transcriptional activities as well as the extent of antiproliferative effects of type I interferons. These findings characterize SCF(HOS) as an E3 ubiquitin ligase that is essential for ubiquitination, proteolysis and down-regulation of IFNAR1, and implicate HOS in the regulation of cellular responses to IFNalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532120      PMCID: PMC213778          DOI: 10.1093/emboj/cdg524

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

Review 1.  Themes and variations on ubiquitylation.

Authors:  A M Weissman
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.

Authors:  Matti Davis; Ada Hatzubai; Jens S Andersen; Etti Ben-Shushan; Gregory Zvi Fisher; Avraham Yaron; Asne Bauskin; Frank Mercurio; Matthias Mann; Yinon Ben-Neriah
Journal:  Genes Dev       Date:  2002-02-15       Impact factor: 11.361

3.  Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I.

Authors:  D J Katzmann; M Babst; S D Emr
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

4.  HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.

Authors:  S Y Fuchs; A Chen; Y Xiong; Z Q Pan; Z Ronai
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

Review 5.  Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.

Authors:  Omar Khan; Rana Zabad; Christina Caon; Marina Zvartau-Hind; Alexandros Tselis; Robert Lisak
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Current treatment for chronic hepatitis C.

Authors:  G L Davis
Journal:  Rev Gastroenterol Disord       Date:  2001

7.  An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.

Authors:  Michael Ohh; William Y Kim; Javid J Moslehi; Yuzhi Chen; Vincent Chau; Margaret A Read; William G Kaelin
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

Review 8.  Negative regulation of cytokine signaling.

Authors:  C J Greenhalgh; D J Hilton
Journal:  J Leukoc Biol       Date:  2001-09       Impact factor: 4.962

9.  Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.

Authors:  Jean-Patrick Parisien; Joe F Lau; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 10.  Cancer immunotherapy: the interferon-alpha experience.

Authors:  John Kirkwood
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

View more
  108 in total

1.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

2.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.

Authors:  Hui Zheng; Juan Qian; Christopher J Carbone; N Adrian Leu; Darren P Baker; Serge Y Fuchs
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

4.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

5.  Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor.

Authors:  Gamze Betul Bulut; Rita Sulahian; Yue Ma; Nai-wen Chi; Lily Jun-shen Huang
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

6.  Jun activation domain-binding protein 1 (JAB1) is required for the optimal response to interferons.

Authors:  Ryuta Muromoto; Maiko Nakajima; Koki Hirashima; Toru Hirao; Shigeyuki Kon; Kazuya Shimoda; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

7.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells.

Authors:  Juu-Chin Lu; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

9.  Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Authors:  K G Suresh Kumar; Jianghuai Liu; Ying Li; Duonan Yu; Andrei Thomas-Tikhonenko; Meenhard Herlyn; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

10.  Identification of a consensus site for TRAF6/p62 polyubiquitination.

Authors:  Trafina Jadhav; Thangiah Geetha; Jianxiong Jiang; Marie W Wooten
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.